Opportunity Information: Apply for CDC RFA DP13 131404CONT16
Apply for CDC RFA DP13 131404CONT16
- The HHS-CDC in the health sector is offering a public funding opportunity titled "Consortium of National Networks to Impact Populations Experiencing Tobacco-Related and Cancer Health Disparities" and is now available to receive applicants.
- Interested and eligible applicants and submit their applications by referencing the CFDA number(s): 93.283.
- This funding opportunity was created on Feb 17, 2016 and posted on Feb 17, 2016.
- Applicants must submit their applications by Apr 22, 2016. (Agency may still review applications by suitable applicants for the remaining/unused allocated funding in 2026.)
- The number of recipients for this funding is limited to 50 candidate(s).
- Eligible applicants include: Others (see text field entitled Additional Information on Eligibility for clarification).
[Watch] Creating a grant proposal using the step-by-step wizard inside the applicant portal:
Opportunity Summary:
The grant opportunity titled "Consortium of National Networks to Impact Populations Experiencing Tobacco-Related and Cancer Health Disparities" is a continuation funding announcement from the U.S. Department of Health and Human Services, Centers for Disease Control and Prevention (HHS-CDC). It is issued under Funding Opportunity Number CDC RFA DP13-131404CONT16 and is categorized as a health-related program (CFDA 93.283). The overall focus is on supporting a coordinated consortium structure made up of national networks that can reduce tobacco-related and cancer health disparities, meaning it aims to improve prevention, control, and related outcomes among populations that experience unequal burdens of tobacco use and cancer.
This opportunity uses a cooperative agreement as the funding instrument. A cooperative agreement generally indicates that CDC expects to have substantial involvement in the work beyond standard grant oversight, such as participating in planning, providing technical assistance, helping align activities with national public health priorities, and supporting coordination across awardees. The word "consortium" and the emphasis on "national networks" suggest the work is intended to be collaborative and scalable, leveraging organizations that already have reach into communities experiencing disproportionate impacts. The intent is typically to strengthen infrastructure, partnerships, and coordinated strategies that can move evidence-based interventions into real-world practice where disparities are most pronounced.
The announcement is explicitly listed as continuation funding, which usually means it is designed to continue or extend work already underway through a prior or existing project period rather than start an entirely new program from scratch. That framing often reflects an interest in maintaining momentum, sustaining established networks, and deepening implementation and impact over time. The listing notes an expected 50 awards, which points to a broad multi-award approach where many network members or partner organizations may be supported under the consortium umbrella, potentially covering diverse populations, geographies, or priority disparity groups.
In terms of eligibility, the public listing indicates "Others (see text field entitled Additional Information on Eligibility for clarification)," meaning eligibility is not limited to a single standard applicant type in the high-level summary and would be defined in the full announcement. In practice, programs like this often involve national, regional, or community-based organizations, coalitions, academic or public health partners, and other entities that have demonstrated capacity to reach and serve populations experiencing tobacco-related and cancer disparities. Because the provided source data does not include the detailed eligibility text, the safest interpretation is that eligibility requirements were specified in the full funding notice and likely tailored to continuation recipients and/or specific network participants.
Key administrative details in the listing include an original and current closing date of April 22, 2016, with a posting and creation date of February 17, 2016. The award ceiling is shown as 0, which commonly indicates that the maximum award amount was not specified in the simplified listing or was to be determined by CDC based on availability of funds, approved work plans, or continuation budget parameters. The opportunity category is labeled as "Continuation," reinforcing that these awards were intended to support ongoing efforts rather than solicit brand-new applicants broadly.
Taken together, the grant can be summarized as a CDC-managed cooperative agreement continuation opportunity intended to fund and coordinate a multi-award consortium of national networks working to reduce tobacco-related and cancer health disparities, using collaborative, evidence-informed public health strategies and sustained partnership infrastructure, with awards administered under CFDA 93.283 and applications due in April 2016.
FAQs: Consortium of National Networks to Impact Populations Experiencing Tobacco-Related and Cancer Health Disparities
What is the title of this grant opportunity?
The opportunity is titled "Consortium of National Networks to Impact Populations Experiencing Tobacco-Related and Cancer Health Disparities."
Which federal agency is offering this funding?
The funding is offered by the U.S. Department of Health and Human Services, Centers for Disease Control and Prevention (HHS-CDC).
What is the Funding Opportunity Number (FON)?
The Funding Opportunity Number is CDC RFA DP13-131404CONT16.
What CFDA number is associated with this program?
The program is listed under CFDA 93.283.
What is the overall purpose of the opportunity?
The purpose is to support a coordinated consortium structure made up of national networks that can reduce tobacco-related and cancer health disparities. The emphasis is on improving prevention, control, and related outcomes among populations that experience unequal burdens of tobacco use and cancer.
What types of disparities does the program aim to address?
It focuses on tobacco-related and cancer health disparities, specifically among populations experiencing disproportionate impacts and unequal burdens related to tobacco use and cancer outcomes.
What does it mean that the work is organized as a "consortium" of "national networks"?
It suggests the funded work is intended to be collaborative and scalable, leveraging organizations and networks that already have reach into communities experiencing disproportionate impacts. The consortium approach typically centers on coordination, shared strategies, partnership infrastructure, and collective implementation across multiple network participants.
What is the funding instrument for this opportunity?
The funding instrument is a cooperative agreement.
How is a cooperative agreement different from a typical grant (based on this listing)?
A cooperative agreement indicates CDC expects to have substantial involvement beyond standard grant oversight. Based on the provided description, this may include participating in planning, providing technical assistance, helping align activities with national public health priorities, and supporting coordination across awardees.
Is this opportunity for new projects or existing work?
It is explicitly listed as continuation funding, which generally means it is intended to continue or extend work already underway from a prior or existing project period rather than starting an entirely new program from scratch.
What does "continuation" imply about who should apply?
Based on the description, "continuation" typically reflects an interest in maintaining momentum, sustaining established networks, and deepening implementation and impact over time. The detailed eligibility requirements are not included in the information provided, so the full funding notice would define whether the opportunity was limited to existing recipients and/or specific network participants.
How many awards were expected?
The listing notes an expected 50 awards.
What does an expected 50 awards suggest about the program structure?
It points to a broad, multi-award approach where many network members or partner organizations may be supported under the consortium umbrella, potentially spanning diverse populations, geographies, or priority disparity groups.
Who is eligible to apply?
The high-level listing indicates eligibility as "Others (see text field entitled Additional Information on Eligibility for clarification)." The detailed eligibility language is not included in the provided information, so eligibility would be defined in the full announcement.
Does the listing provide specific eligible entity types?
No. The listing only states "Others" and refers applicants to an additional eligibility text field in the full notice, which is not included in the information provided here.
What kinds of organizations might typically be involved (as implied by the description)?
The description implies involvement from organizations with demonstrated reach into populations experiencing tobacco-related and cancer disparities, potentially including national, regional, or community-based organizations, coalitions, academic or public health partners, and other entities. However, the exact eligible categories would be specified in the full funding notice.
What was the application due date?
The original and current closing date shown in the listing is April 22, 2016.
When was the opportunity posted?
The posting and creation date listed is February 17, 2016.
What is the opportunity category?
The opportunity category is labeled as "Continuation."
Is an award maximum (ceiling) listed?
The award ceiling is shown as 0.
What does an award ceiling of 0 mean in this listing?
In simplified listings, a ceiling of 0 commonly indicates the maximum award amount was not specified there or was to be determined by CDC based on factors such as availability of funds, approved work plans, or continuation budget parameters.
Is this opportunity primarily focused on direct services, research, or coordination?
Based on the provided description, the core emphasis is on supporting a coordinated consortium structure and strengthening infrastructure, partnerships, and coordinated strategies to move evidence-based interventions into real-world practice where disparities are most pronounced.
What role is CDC expected to play during the project?
Because this is a cooperative agreement, CDC is expected to have substantial involvement, such as participating in planning, providing technical assistance, aligning activities with national public health priorities, and supporting coordination across awardees.
What is the simplest summary of this funding opportunity?
It is a CDC-managed cooperative agreement continuation opportunity under CFDA 93.283 intended to fund and coordinate a multi-award consortium of national networks working to reduce tobacco-related and cancer health disparities, with applications due April 22, 2016.
Browse more opportunities from the same category: Health
Next opportunity: NSF Scholarships in Science, Technology, Engineering, and Mathematics Program
Previous opportunity: Global Health Security Partnership Engagement: Expanding Efforts and Strategies to Protect and Improve Public Health Globally
USGrants.org Applicant Portal:
Are you interested in learning about about how to apply for this government funding opportunity? You can create a free applicant account and receive instant access to our applicant portal that many business owners like you have benefited from.
Apply for CDC RFA DP13 131404CONT16
[Watch] how do funding administrators access proposals?
Applicants also applied for:
Applicants who have applied for this opportunity (CDC RFA DP13 131404CONT16) also looked into and applied for these:
| Funding Opportunity |
|---|
| Expanding Partnerships and Disseminating HIV Prevention Materials to Reduce HIV and other STDs among Adolescents through National Non-Governmental Organizations Apply for CDC RFA PS16 1603 Funding Number: CDC RFA PS16 1603 Agency: HHS-CDC-NCHHSTP Category: Health Funding Amount: $400,000 |
| Provider Education and Public Awareness about Primary Immunodeficiency Disease Apply for CDC RFA OE12 120305CONT16 Funding Number: CDC RFA OE12 120305CONT16 Agency: HHS-CDC Category: Health Funding Amount: Case Dependent |
| Cooperative Agreement with the National Center for Disease Control and Public Health (NCDC) of the Republic of Georgia Apply for CDC RFA GH12 1259205CONT16 Funding Number: CDC RFA GH12 1259205CONT16 Agency: HHS-CDC Category: Health Funding Amount: Case Dependent |
| Protecting and Improving Public Health Globally: Building and Strengthening Public Health Impact, Systems, Capacity and Security Apply for CDC RFA GH15 162702CONT16 Funding Number: CDC RFA GH15 162702CONT16 Agency: HHS-CDC Category: Health Funding Amount: Case Dependent |
| Rwandan Rural Sanitation Activity (RRSA) Apply for RFA 696 16 000002 Funding Number: RFA 696 16 000002 Agency: USAID-RWA Category: Health Funding Amount: $10,700,000 |
| Sustaining Influenza Surveillance Networks and Response to Seasonal and Pandemic Influenza by National Health Authorities outside the United States Apply for CDC RFA IP13 130404CONT16 Funding Number: CDC RFA IP13 130404CONT16 Agency: HHS-CDC Category: Health Funding Amount: Case Dependent |
| NIAID SBIR-Technology Transfer Direct Phase II (R44) Apply for RFA AI 16 009 Funding Number: RFA AI 16 009 Agency: HHS-NIH11 Category: Health Funding Amount: Case Dependent |
| Surveillance and Response to Avian and Pandemic Influenza by National Health Authorities outside the United States Apply for CDC RFA IP13 130604CONT16 Funding Number: CDC RFA IP13 130604CONT16 Agency: HHS-CDC Category: Health Funding Amount: Case Dependent |
| Botswana Comprehensive Care and Support for Orphans and Vulnerable Children Apply for RFA 674 16 000004 Funding Number: RFA 674 16 000004 Agency: USAID-SAF Category: Health Funding Amount: $12,300,000 |
| State Oral Disease Prevention Program Apply for CDC RFA DP13 130704CONT16 Funding Number: CDC RFA DP13 130704CONT16 Agency: HHS-CDC Category: Health Funding Amount: Case Dependent |
| Health Department Demonstration Projects to Reduce HIV Infections and Improve Engagement in HIV Medical Care among Men Who Have Sex with Men (MSM) and Transgender Persons Apply for CDC RFA PS15 150602CONT16 Funding Number: CDC RFA PS15 150602CONT16 Agency: HHS-CDC Category: Health Funding Amount: Case Dependent |
| Strengthening a Regional Public Health Surveillance, Capacity and Laboratory Network for Central America with the Secretaria General del Sistema de la Integracion Centroamericana (SG-SICA)/Consejo de Ministros de Salud de Centroamerica (COMISCA) Apply for CDC RFA GH15 160702CONT16 Funding Number: CDC RFA GH15 160702CONT16 Agency: HHS-CDC Category: Health Funding Amount: Case Dependent |
| Institutional Research and Academic Career Development Awards (IRACDA) (K12) Apply for PAR 16 103 Funding Number: PAR 16 103 Agency: HHS-NIH11 Category: Health Funding Amount: Case Dependent |
| Limited Competition: NIGMS Legacy Community-Wide Scientific Resources (R24) Apply for PAR 16 104 Funding Number: PAR 16 104 Agency: HHS-NIH11 Category: Health Funding Amount: Case Dependent |
| Newborn Screening for Severe Combined Immunodeficiency (SCID) Apply for CDC RFA EH15 150402CONT16 Funding Number: CDC RFA EH15 150402CONT16 Agency: HHS-CDC Category: Health Funding Amount: Case Dependent |
| Protecting and Improving Public Health Systems Globally: Building and Strengthening Public Health Impact, Systems, Capacity and Security Apply for CDC RFA GH14 141803CONT16 Funding Number: CDC RFA GH14 141803CONT16 Agency: HHS-CDC Category: Health Funding Amount: Case Dependent |
| Prescription Drug Overdose Prevention for States Apply for CDC RFA CE15 150102CONT16 Funding Number: CDC RFA CE15 150102CONT16 Agency: HHS-CDC Category: Health Funding Amount: Case Dependent |
| Bridges to the Doctorate (R25) Apply for PAR 16 109 Funding Number: PAR 16 109 Agency: HHS-NIH11 Category: Health Funding Amount: $300,000 |
| Bridges to the Baccalaureate (R25) Apply for PAR 16 110 Funding Number: PAR 16 110 Agency: HHS-NIH11 Category: Health Funding Amount: $300,000 |
| Biomarkers for the Lewy Body Dementias (U01) Apply for RFA NS 16 022 Funding Number: RFA NS 16 022 Agency: HHS-NIH11 Category: Health Funding Amount: Case Dependent |
Grant application guides and resources
It is always free to apply for government grants. However the process may be very complex depending on the funding opportunity you are applying for. Let us help you!
Apply for Grants
Premium leads for funding administrators, grant writers, and loan issuers
Thousands of people visit our website for their funding needs every day. When a user creates a grant proposal and files for submission, we pass the information on to funding administrators, grant writers, and government loan issuers.
If you manage government grant programs, provide grant writing services, or issue personal or government loans, we can help you reach your audience.
Subscribe to Leads
Request more information:
Would you like to learn more about this funding opportunity, similar opportunities to "CDC RFA DP13 131404CONT16", eligibility, application service, and/or application tips? Submit an inquiry below:
Don't forget to subscribe to our grant alerts mailing list to receive weekly alerts on new and updated grant funding opportunities like this one in your email.